AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)
CUSIP: 03152W109
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 312,579,912
- Total 13F shares
- 275,685,202
- Share change
- -1,395,891
- Total reported value
- $2,723,386,669
- Put/Call ratio
- 65%
- Price per share
- $9.88
- Number of holders
- 241
- Value change
- -$230,544,914
- Number of buys
- 137
- Number of sells
- 136
Quarterly Holders Quick Answers
What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03152W109:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
8%
|
25,112,048
|
$579,837,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
23,845,433
|
$550,591,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7%
|
21,877,442
|
$505,149,000 | — | 31 Dec 2020 | |
| Redmile Group, LLC |
13F
|
Company |
6.6%
|
20,620,490
|
$476,127,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
4.1%
|
12,730,857
|
$293,954,000 | — | 31 Dec 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.6%
|
11,247,208
|
$259,701,000 | — | 31 Dec 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
10,136,467
|
$234,052,000 | — | 31 Dec 2020 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
2.9%
|
9,000,000
|
$207,810,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.7%
|
8,458,917
|
$195,317,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
7,909,391
|
$182,628,000 | — | 31 Dec 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
2.5%
|
7,867,114
|
$181,652,000 | — | 31 Dec 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.3%
|
7,079,596
|
$163,468,000 | — | 31 Dec 2020 | |
| LONE PINE CAPITAL LLC |
13F
|
Company |
2.1%
|
6,678,788
|
$154,213,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.8%
|
5,513,614
|
$127,309,000 | — | 31 Dec 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.5%
|
4,702,583
|
$108,583,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
4,059,103
|
$93,724,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
1.2%
|
3,703,955
|
$85,525,000 | — | 31 Dec 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.1%
|
3,287,035
|
$75,898,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
3,225,905
|
$74,486,000 | — | 31 Dec 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1%
|
3,190,052
|
$73,659,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.94%
|
2,952,906
|
$68,183,000 | — | 31 Dec 2020 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.93%
|
2,917,200
|
$67,358,000 | — | 31 Dec 2020 | |
| NORGES BANK |
13F
|
Company |
0.88%
|
2,747,126
|
$63,431,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.85%
|
2,661,034
|
$61,443,000 | — | 31 Dec 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.8%
|
2,500,000
|
$57,725,000 | — | 31 Dec 2020 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.8%
|
2,495,104
|
$57,612,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.77%
|
2,404,484
|
$55,519,000 | — | 31 Dec 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
0.74%
|
2,325,000
|
$53,684,000 | — | 31 Dec 2020 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.72%
|
2,257,751
|
$52,131,000 | — | 31 Dec 2020 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.71%
|
2,204,140
|
$50,894,000 | — | 31 Dec 2020 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.68%
|
2,130,000
|
$49,182,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.66%
|
2,049,362
|
$47,320,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.61%
|
1,897,967
|
$43,825,000 | — | 31 Dec 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.58%
|
1,815,829
|
$41,927,000 | — | 31 Dec 2020 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.57%
|
1,786,637
|
$41,253,000 | — | 31 Dec 2020 | |
| Novo Holdings A/S |
13F
|
Company |
0.54%
|
1,684,795
|
$38,902,000 | — | 31 Dec 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.52%
|
1,629,983
|
$37,636,000 | — | 31 Dec 2020 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.49%
|
1,534,604
|
$35,434,000 | — | 31 Dec 2020 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.47%
|
1,482,467
|
$34,230,000 | — | 31 Dec 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.45%
|
1,400,793
|
$32,344,000 | — | 31 Dec 2020 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.43%
|
1,350,610
|
$31,186,000 | — | 31 Dec 2020 | |
| Fairmount Funds Management LLC |
13F
|
Company |
0.42%
|
1,315,395
|
$30,372,000 | — | 31 Dec 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.4%
|
1,250,000
|
$28,863,000 | — | 31 Dec 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.38%
|
1,179,684
|
$27,239,000 | — | 31 Dec 2020 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
1,071,651
|
$24,744,000 | — | 31 Dec 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.33%
|
1,046,176
|
$24,156,000 | — | 31 Dec 2020 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.33%
|
1,038,136
|
$23,971,000 | — | 31 Dec 2020 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.33%
|
1,029,000
|
$23,760,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.32%
|
1,000,300
|
$23,097,000 | — | 31 Dec 2020 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.3%
|
949,306
|
$21,919,000 | — | 31 Dec 2020 |
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2021
As of 31 Mar 2021,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
241 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
275,685,202 shares.
The largest 10 holders included
VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., Redmile Group, LLC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, Palo Alto Investors LP, and STATE STREET CORP.
This page lists
241
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
267
Q1 2021 holders
241
Holder diff
-26
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.